ACC patients with low SLC41A3 expression had worse OS/DSS than those with high SLC41A3 expression, regardless of MSI level, probably because MSI alone had no effect on clinical outcome (Figures 10A, D). Here, SLC41A3 is linked to adrenal cortex carcinoma.